Skip to search formSkip to main contentSkip to account menu

IMGN853

National Institutes of Health

Related topics

Related topics

5 relations

Broader (4)

Antibodies, Monoclonal, HumanizedImmunoconjugatesMaytansineMirvetuximab Soravtansine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The KRAS Membrane Anchor Regulates Signaling through Lipid Specificity.
KRAS lipid specificity controls signaling and is not determined solely by electrostatic attraction. 
2017
2017
IMGN853 Is Active in Patients with FRα-Positive Ovarian Cancer.
A FRα-targeting antibody-drug conjugate induces responses in patients with platinum-resistant tumors. 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)